0001213900-23-072249.txt : 20230830 0001213900-23-072249.hdr.sgml : 20230830 20230830164627 ACCESSION NUMBER: 0001213900-23-072249 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230828 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Townsend John CENTRAL INDEX KEY: 0001511906 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 231225822 MAIL ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 ownership.xml X0508 4 2023-08-28 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001511906 Townsend John C/O UNICYCIVE THERAPEUTICS LOS ALTOS CA 94022 0 1 0 0 Chief Financial Officer 0 Stock Options 0.75 2023-08-28 4 A 0 570329 0 A 2033-08-28 Common Stock 570329 647190 D 142,582 of the stock options vest on March 6, 2024 and 1/36th of the remaining options vest at the end of each successive month thereafter. /s/ John Townsend 2023-08-30